Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2024 | FY2025 |
|---|---|---|
| Revenue | $31.6M | $47.3M |
| Revenue growth | — | 49.6% |
| Gross profit | $24.3M | $36.2M |
| Gross margin | 77.0% | 76.5% |
| Operating income | -$14.7M | -$26.3M |
| Operating margin | -46.3% | -55.6% |
| Net income | -$15.6M | -$40.4M |
| Net margin | -49.4% | -85.3% |
| EPS (diluted) | -$242.04 | -$4.65 |
| Fiscal year | FY2024 | FY2025 |
|---|---|---|
| Operating cash flow | -$14.1M | -$28.6M |
| Capital expenditures | $4.01M | $7.41M |
| Free cash flow | -$18.2M | -$36.0M |
| Fiscal year | FY2024 | FY2025 |
|---|---|---|
| Cash & equivalents | $6.12M | $26.9M |
| Total assets | $43.1M | $170M |
| Total liabilities | $23.3M | $29.2M |
| Long-term debt | $14.7M | $14.9M |
| Shareholders' equity | -$54.7M | $141M |
| Retained earnings | -$57.0M | -$97.4M |
| Shares (wtd avg diluted) | 64.5B | 8.67M |
Every figure is extracted from SHOULDER INNOVATIONS, INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.